Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply
Aliment Pharmacol Ther
.
2024 Aug;60(3):427-428.
doi: 10.1111/apt.18136.
Epub 2024 Jun 24.
Authors
Tsz Hong Yiu
1
,
Yanna Ko
2
3
,
Aviv Pudipeddi
3
,
Patrizia Natale
1
4
5
,
Rupert W Leong
3
Affiliations
1
School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
2
Campbelltown and Camden Hospitals, Canterbury Hospital, Western Sydney University, Sydney, New South Wales, Australia.
3
Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
4
Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J) University of Bari Aldo Moro, Bari, Italy.
5
Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
PMID:
38922940
DOI:
10.1111/apt.18136
No abstract available
Publication types
Letter
Comment
MeSH terms
Gastrointestinal Agents / therapeutic use
Humans
Inflammatory Bowel Diseases* / drug therapy
Treatment Outcome
Substances
Gastrointestinal Agents